Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Kraft Heinz to Sell Indian Brands Complan, Glucon-D, Nycil and Sampriti to Zydus Wellness Limited

      Kraft Heinz to Sell Indian Brands Complan, Glucon-D, Nycil and Sampriti to Zydus Wellness Limited

      Medical Dialogues Bureau25 Oct 2018 10:01 AM IST
      New Delhi: The Kraft Heinz Company announced that it has entered into a definitive agreement to sell Indian brands Complan, Glucon-D, Nycil and...
      Philips launches first start-up program for artificial intelligence in healthcare

      Philips launches first start-up program for artificial intelligence in healthcare

      Medical Dialogues Bureau25 Oct 2018 9:38 AM IST
      New Delhi: Royal Philips, a global leader in health technology, has recently announced the launch of its first global start-up collaboration program...
      ED Files fresh charge sheet in Rs 50-billion Sterling Biotech scam

      ED Files fresh charge sheet in Rs 50-billion Sterling Biotech scam

      Medical Dialogues Bureau25 Oct 2018 9:15 AM IST
      New Delhi: The Enforcement Directorate (ED) has recently filed its supplementary charge sheet in a Delhi court in the over Rs 50 billion money...
      Interpol seizes 500 tonnes of illicit drugs in worldwide raids

      Interpol seizes 500 tonnes of illicit drugs in worldwide raids

      Medical Dialogues Bureau25 Oct 2018 9:00 AM IST
      PARIS: Coordinated police raids in 116 countries have netted 500 tonnes of illicit pharmaceuticals available online, including fake cancer...
      Pfizer-Lilly Non-Opioid Drug Tanezumab decreases Osteoarthritis Pain: Shows late-stage Study

      Pfizer-Lilly Non-Opioid Drug Tanezumab decreases Osteoarthritis Pain: Shows late-stage Study

      Medical Dialogues Bureau24 Oct 2018 4:44 PM IST
      New Delhi: A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients reported a...
      Zydus Cadila gets USFDA nod to Market Generic Drug Clobazam for Seizures Treatment

      Zydus Cadila gets USFDA nod to Market Generic Drug Clobazam for Seizures Treatment

      Medical Dialogues Bureau24 Oct 2018 3:00 PM IST
      New Delhi: Drug firm Zydus Cadila has announced that it has received the final nod from the US health regulator to market generic Clobazam tablets...
      J&J offers 2.1 billion dollars to acquire Japan Cosmetics firm Ci:z

      J&J offers 2.1 billion dollars to acquire Japan Cosmetics firm Ci:z

      Medical Dialogues Bureau24 Oct 2018 1:00 PM IST
      TOKYO: U.S. healthcare conglomerate Johnson & Johnson had recently announced that it will buy all outstanding shares of Japanese skincare firm...
      BCPE Max Dutchs acquisition of Gist Brocades, DSM Sinochem Approved: CCI

      BCPE Max Dutch's acquisition of Gist Brocades, DSM Sinochem Approved: CCI

      Medical Dialogues Bureau24 Oct 2018 10:00 AM IST
      New Delhi: Fair trade regulator CCI has recently approved the acquisition of sole control of Gist-Brocades International and Singapore-based DSM...
      Ciplas South African arm completes acquisition of Mirren Ltd

      Cipla's South African arm completes acquisition of Mirren Ltd

      Medical Dialogues Bureau24 Oct 2018 9:45 AM IST
      New Delhi: Drug major Cipla has recently stated that its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd. Cipla...
      Jubilant Life Q2 profit up 67 Percent to Rs 210 Crore

      Jubilant Life Q2 profit up 67 Percent to Rs 210 Crore

      Medical Dialogues Bureau24 Oct 2018 9:32 AM IST
      New Delhi: Jubilant Life Sciences has recently reported 67.18 per cent rise in consolidated net profit to Rs 209.77 crore for the quarter ended...
      China Biotech Keeps Fans Despite Wild Swings, High Valuation.. Report

      China Biotech Keeps Fans Despite Wild Swings, High Valuation.. Report

      Medical Dialogues Bureau24 Oct 2018 9:00 AM IST
      New Delhi: Chinese biotechnology stocks have been hit by a wave of bad news since the summer.Bloomberg reports that the shares plunged about 30 per...
      Unregulated sale of prescription medicines: PIL in HC against drug regulators

      Unregulated sale of prescription medicines: PIL in HC against drug regulators

      Medical Dialogues Bureau23 Oct 2018 6:07 PM IST
      New Delhi: A Public Interest Litigation (PIL) was filed in Bombay High court by Mumbai based lawyer Bharat Kothari against the Government of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok